‘Game-changing’ spit test could shrink years-long wait for diagnosis of condition that affects 190M women

UK regulators have approved two non‑invasive spit tests that can identify endometriosis in roughly 45 minutes, a stark contrast to the average nine‑year patient journey reported by many sufferers. Deccan Herald highlighted the reduction from years to minutes, while EMJ and Healthcare Today underscored the promise of faster GP diagnoses. The rapid turnaround is expected to shorten referral cycles and reduce the emotional toll of prolonged uncertainty.

The Jersey Evening Post reported that the tests are not yet scheduled for the island, suggesting supply or commissioning gaps. hyphenonline.com noted potential cultural benefits for Muslim women but offered no data on distribution or training. BBC coverage featured a personal account of delayed diagnosis but did not provide specifics on test accuracy or cost, leaving a thin factual base for how quickly the tools will reach everyday clinics. Key uncertainties remain.

The New York Post billed the test “game‑changing,” but without independent performance data, clinicians lack a full risk‑benefit picture. Future reporting will need to track adoption across UK regions, cost‑reimbursement decisions, and any regulatory actions in jurisdictions like Jersey that have so far been excluded.